Financial Results Summary
Standalone Financial Results (₹ in Million)
For Year Ended 31 March 2026:
- Revenue from operations: ₹31,857.62 (vs. ₹30,903.69 in FY25)
- Total income: ₹33,318.26 (vs. ₹32,097.93 in FY25)
- Profit before tax: ₹7,266.49 (vs. ₹6,739.89 in FY25)
- Profit after tax: ₹5,431.39 (vs. ₹5,019.48 in FY25)
- Basic and diluted EPS: ₹10.88 (vs. ₹10.06 in FY25)
Quarter Ended 31 March 2026:
- Revenue from operations: ₹6,714.91
- Profit after tax: ₹1,106.10
- Basic and diluted EPS: ₹2.22 (not annualized)
Consolidated Financial Results (₹ in Million)
For Year Ended 31 March 2026:
- Revenue from operations: ₹32,383.15
- Profit after tax: ₹5,429.75
- Basic and diluted EPS: ₹10.88
Dividend Declaration
The Board of Directors declared a final dividend of ₹1.30 per equity share (13% on face value of ₹10) for FY 2025-26, aggregating ₹648.89 million. This is subject to approval by members at the ensuing Annual General Meeting.
Exceptional Items
The company recorded an exceptional item of ₹151.86 million in the quarter and year ended December 31, 2025, relating to the incremental impact of implementing the four Labour Codes notified by the Government of India on November 21, 2025.
Balance Sheet Highlights (Standalone as of 31 March 2026)
- Total assets: ₹44,341.10 million
- Equity share capital: ₹4,991.46 million (49,914,736 equity shares of ₹10 each)
- Other equity: ₹28,850.38 million
- Total equity: ₹33,841.84 million
- Current assets: ₹33,024.39 million (including inventories ₹7,607.71 million, cash and cash equivalents ₹675.29 million)
- Current liabilities: ₹9,490.91 million
Cash Flow Statement (Standalone FY26)
- Net cash from operating activities: ₹4,434.01 million
- Net cash used in investing activities: ₹(3,290.45) million
- Net cash used in financing activities: ₹(811.69) million
- Net increase in cash and cash equivalents: ₹331.87 million
Key Notes and Disclosures
1. The business is seasonal and performance depends on monsoon and other climatic conditions
2. Labour Code implementation impact considered as exceptional item due to regulatory-driven, non-recurring nature
3. Ongoing litigation regarding Glyphosate notification - Government counsel stated notification will not be implemented till disposal of petitions
4. Only one reportable segment: agro-chemicals
5. Q4 March 2026 figures are balancing figures between audited full year and published unaudited YTD figures up to Q3
6. Consolidated results include two subsidiaries: Barrix Agro Sciences Private Limited and Excel Crop Care (Africa) Limited (under liquidation)
Audit Details
Results reviewed by Audit Committee and approved by Board of Directors on 26 May 2026. Audited by B S R & Co. LLP, who issued unqualified opinions on both standalone and consolidated financial results.